The Centers for Medicare and Medicaid Services (CMS) has taken a landmark step in modernizing chronic care delivery. It officially opened the ACCESS Model — Advancing Chronic Care with Effective, Scalable Solutions — to technology organizations. Moreover, healthcare AI company Innovaccer has joined the program’s first cohort, ahead of the July 2026 launch.
What Is the CMS ACCESS Model?
The ACCESS Model is a voluntary, 10-year Medicare payment initiative. CMS designed it to expand access to technology-supported care for people living with chronic conditions. Crucially, it rewards health outcomes rather than the volume of services delivered.
Four Clinical Tracks Drive the Program
The model covers four tracks targeting conditions that affect more than two-thirds of Medicare fee-for-service (FFS) beneficiaries:
- Early Cardio-Kidney-Metabolic (eCKM): Hypertension, dyslipidemia, obesity, prediabetes
- Cardio-Kidney-Metabolic (CKM): Diabetes, chronic kidney disease, cardiovascular disease
- Musculoskeletal (MSK): Chronic pain conditions
- Behavioral Health (BH): Anxiety, depression
Participating organizations earn recurring payments for managing qualifying conditions. However, they receive full payment only when patients achieve measurable health goals — for example, lowering blood pressure by 10 mmHg.
Why CMS Opened Medicare to Tech Firms
Traditional Medicare fee-for-service payments were built around defined activities. They did not align well with the way digital health tools deliver care. As a result, millions of Medicare beneficiaries had limited access to telehealth, remote monitoring, and AI-powered care management.
CMS recognized this gap. Therefore, it created the ACCESS framework to let technology organizations — not just traditional providers — directly serve Medicare patients. The initial application deadline was April 1, 2026, though CMS extended it after receiving more than 150 applications, far exceeding expectations.
Big Tech Is Already in the Race
Consumer trust in Big Tech health-related AI now rivals trust in provider-developed AI. Consequently, large technology firms are actively pursuing the ACCESS opportunity. This competitive landscape makes early participation especially valuable for healthcare AI companies like Innovaccer.
Innovaccer Joins the First ACCESS Cohort
On April 13, 2026, Innovaccer announced that CMS accepted its application under Story Health Partners for the ACCESS Model. Notably, the company secured acceptance across both the eCKM and CKM tracks, covering conditions such as hypertension, diabetes, and chronic kidney disease.
Abhinav Shashank, Cofounder and CEO of Innovaccer, described the significance:
Trusted by Leading Health Systems
Innovaccer already works with major organizations including Orlando Health, Adventist HealthCare, and Banner Health. These partnerships give the company established infrastructure and clinical experience to scale quickly within the ACCESS framework.
How the Zero-Risk Model Works for Health Systems
Innovaccer designed its ACCESS participation model to be entirely zero-risk for health system partners. Health systems continue billing Medicare fee-for-service without any disruption to existing workflows. Meanwhile, Innovaccer handles all technology-enabled care delivery and assumes the outcome performance risk.
End-to-End Care Management
Once a patient enrolls, Innovaccer manages the entire care journey. This includes:
- Program orientation and care plan goal-setting
- Baseline CMS submissions and PCP coordination
- Remote monitoring and medication optimization
- Triage risk alerts with real-time clinical visibility for care teams
Importantly, patient relationships remain with the health system throughout. All in-person care routes back to the health system’s provider network. Real-time clinical data flows back to care teams at every step.
Adaptive Program Intelligence Powers Care Delivery
Central to Innovaccer’s approach is its proprietary Adaptive Program Intelligence engine. This technology dynamically adjusts care intensity based on each patient’s engagement and response patterns. Depending on need, it shifts between AI-only support, hybrid care, or high-touch human intervention — all in real time.
Infrastructure Built to Scale
Innovaccer’s Healthcare Intelligence Platform unifies enterprise data and applies AI to automate administrative workflows. Furthermore, it drives measurable margin expansion across health systems, payers, and life sciences organizations. This combination of unified data and adaptive intelligence positions Innovaccer as a strong contender in the ACCESS ecosystem.
What This Means for Medicare Patients
For Medicare beneficiaries, the ACCESS Model opens an entirely new care pathway. Patients with qualifying chronic conditions gain access to technology-enabled services — telehealth consultations, wearable device monitoring, and AI-guided lifestyle coaching — without incurring additional cost-sharing burdens.
Additionally, CMS will maintain a public directory listing each ACCESS participant’s tracks, tools, and risk-adjusted outcomes. This transparency helps patients make informed choices about their care providers.
Key Takeaways
The CMS ACCESS Model marks a turning point in Medicare’s approach to chronic disease management. By welcoming technology organizations like Innovaccer into the first cohort, CMS accelerates the shift from activity-based to outcome-based payments. Health systems gain a zero-risk path to participate in value-based care, while Medicare patients receive modern, technology-enabled support for conditions that affect millions. The July 2026 launch sets the stage for a decade-long transformation of American healthcare delivery.
